MSDC-0160

N/A

Report date: 2022/11/25 17:43:09
NME

Base Information

Drug NameMSDC-0160
Drug Alias NameMitoglitazoneMSD-9C-0160U-91325PNU-91325 +[6
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInsulin sensitizers
TargetsNot applicable
Therapy Area/IndicationsDiabetes Mellitus, Type 2Alzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMetabolic Solutions, Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2Alzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A